Autoimmune Disease Diagnosis - to Register Substantial Expansion by 2022
ID: 1747958
The autoimmune disease diagnosis market is expected to reach USD 4.73 Billion by 2022 from USD 2.85 Billion in 2016 at a CAGR of 8.9%.
(firmenpresse) - Factors driving the growth of this market include high incidence and large economic burden of autoimmune diseases, increasing healthcare expenditure, and growing access to medical insurance in the US.
According to a new market research "Autoimmune Disease Diagnosis Market by Products (Consumables, Assay Kits, Instruments, Services), Test Type (Inflammatory Markers, Autoantibodies), Disease (RA, SLE, Thyroiditis, Scleroderma), End Users (Hospitals, Clinical Labs) - Global Forecast to 2022", published by MarketsandMarkets™, the market is expected to reach USD 4.73 Billion by 2022 from USD 3.09 Billion in 2017, at a CAGR of 8.9%.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174826519
Key players in the Autoimmune Disease Diagnosis Market include Thermo Fisher Scientific. (US), Danaher (US), HYCOR Biomedical (US), Siemens (Germany), Bio-Rad Laboratories. (US), and Abbott (US).
Consumables and assay kits are estimated to account for the largest share of the market in 2017
By product and service, the Autoimmune Disease Diagnosis Market is classified into consumables & assay kits, instruments and services. The consumables & assay kits segment is expected to lead the global autoimmune disease diagnosis in 2017. Factors driving the growth of this segment include increasing adoption of consumables in hospitals and clinical laboratories, rising incidence of autoimmune diseases, and increasing demand for quick results.
Browse and in-depth TOC on " Autoimmune Disease Diagnosis Market "
64 – Tables
36 - Figures
121 – Pages
Routine laboratory tests are estimated to command the largest share of the market during the forecast period
On the basis of test type, the Autoimmune Disease Diagnosis Market is categorized into routine laboratory tests, inflammatory markers, autoantibodies and immunologic tests, and other tests. In 2017, the routine laboratory tests segment is estimated to account for the largest share of the global Autoimmune Disease Diagnosis Market. The increasing incidence autoimmune diseases, along with increasing adoption of routine laboratory tests for a variety of diseases are the key factors driving the growth of this end-user segment.
The rheumatoid arthritis segment is expected to dominate the market in 2017
By disease, the market is segmented into systemic lupus erythematosus, rheumatoid arthritis, Sjögren's syndrome, thyroiditis, scleroderma, and other diseases. The rheumatoid disease segment is expected to account for the largest share of the global autoimmune disease diagnosis in 2017. The growth of this segment is mainly driven by the increasing incidences of the disease.
Clinical laboratories are estimated to command the largest share of the market during the forecast period
On the basis of end user, the Autoimmune Disease Diagnosis Market is categorized into clinical laboratories, hospitals, and other end users. The clinical laboratories segment is estimated to account for the largest share of the global Autoimmune Disease Diagnosis Market during the forecast period. The heavy burden of autoimmune diseases, along with the accessibility and availability of diagnosis and treatment instruments in clinical laboratories in a short period of time are the key factors driving the growth of this end-user segment.
North America is estimated to command the largest share of the market
Based on region, the Autoimmune Disease Diagnosis Market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to dominate the Autoimmune Disease Diagnosis Market in 2017. This is attributed to factors such as accessibility to advanced technologies and opportunities for advanced autoimmune diagnostic testing and screening, growing incidence of autoimmune diseases, and technological advancements of autoimmune disease diagnosis in the region as compared to other regions.
Request Sample Pages @
https://www.marketsandmarkets.com/requestsampleNew.asp?id=174826519
Weitere Infos zu dieser Pressemeldung:
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales(at)marketsandmarkets.com
Datum: 27.08.2019 - 14:10 Uhr
Sprache: Deutsch
News-ID 1747958
Anzahl Zeichen: 4404
Kontakt-Informationen:
Ansprechpartner: Dheeraj Shaha
Stadt:
Northbrook
Telefon: 8886006441
Kategorie:
Gesundheitswesen - Medizin
Meldungsart: Erfolgsprojekt
Versandart: Veröffentlichung
Freigabedatum: 27.08.2019
Diese Pressemitteilung wurde bisher 392 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Autoimmune Disease Diagnosis - to Register Substantial Expansion by 2022"
steht unter der journalistisch-redaktionellen Verantwortung von
MnM (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
The growth of this market is mainly driven by factors such as the increasing R&D expenditure in the pharmaceutical industry, increasing focus on miniaturization, technological advancements, and growing prevalence of diseases. The report "Microplate Systems Market by Product (Microplate R
3D Cell Culture Market : Regenerative Medicine to Offer Global Growth In Coming Years ...
A 3D cell culture is an artificially created environment in which biological cells are permitted to grow or interact with their surroundings in all three dimensions. Factors such as rising focus on developing alternative methods for animal testing, funding initiatives from government and private
Immuno Oncology Assays : Research Application Transforming the Industrial Business ...
What the Immuno Oncology Assays Market looks like? Growth in Immuno Oncology Assays Market is largely driven by factors such as the increasing adoption of targeted therapy over traditional therapy and the increasing demand for mAbs. According to the new market research report "Immuno Onco
Weitere Mitteilungen von MnM
Fachjury nominiert 15 Projekte für den Paulaner Salvator-Preis ...
(Mynewsdesk) München, 27.August ? Bis Ende Juli hatten Münchner und Münchnerinnen Zeit sich mit ihrer Idee für den Paulaner Salvator-Preis zu bewerben. Fast 100 Einreichungen waren es am Ende, 15 davon haben es in die finale Runde geschafft. Der mit bis zu 80.000 Euro dotierte Förderpreis soll
Lebensmittel können Einfluss auf Medikamente haben ...
So schwierig es manchmal auch ist, Kindern Medizin zu geben - Eltern sollten zu diesem Zweck auf keinen Fall auf eigene Faust Medikamente mit Nahrungsmitteln vermischen. Milch und Milchprodukte zum Beispiel können die Wirkung einiger Antibiotika reduzieren oder aufheben. "Durch den hohen Ge
LASIK-Behandlung: Neun von zehn Patienten brauchen keine Sehhilfe mehr ...
Tägliche Arbeit, Lesen, Fernsehen, Sport, Spielen mit den Kindern, Straßenverkehr und, und, und: Es gibt kaum einen Bereich, in dem unsere Augen nicht gefordert werden. Aber wessen Sehkraft eingeschränkt ist, der verliert an Lebensqualität - besonders dann, wenn der Betroffene diese Einschränku
DoctorBox integriert als erste digitale Gesundheitsakte den Log-in-Standard Verimi ...
Die Nutzer der DoctorBox App erhalten mit dem kostenfreien Verimi-Zugang eine sichere Alternative zum eigenen Log-in. Nach einer einmaligen Registrierung können sie sich mit Verimi auch in verschiedenen anderen Online-Diensten wie Deutsche Bank, Lufthansa und Telekom mit wenigen Klicks sicher einlo
